Conference Coverage

Sunscreen myths, controversies continue


 

FROM MEDSCAPELIVE LAS VEGAS DERMATOLOGY SEMINAR

Is a higher SPF better?

Many patients believe that the difference between a sunscreen with an SPF of 30 and 60 is negligible. “People generally say that SPF 30 blocks 96.7% of UVB and SPF 60 blocks 98.3%, but that’s the wrong way of looking at it,” said Dr. Wang. Instead, consider “how much of the UV ray is able to pass through the sunscreen and reach your skin and do damage,” he said. If a product with SPF 30 allows a transmission of 3.3% and a product with SPF 60 allows a transmission of 1.7%, “the SPF 60 product has 194% better protection in preventing the UV reaching the skin,” he said.

Over a lifetime, individuals will build up more UV damage with consistent use of SPF 30, compared with SPF 60 products, so this myth is important to dispel, Dr. Wang emphasized. “It is the transmission we should focus on, not the blockage,” he said.

Also, consider that the inactive ingredients matter in sunscreens, such as water resistance and film-forming technology that helps promote full coverage, Dr. Wang said, but don’t discount features such as texture, aesthetics, smell, and color, all of which impact compliance.

“Sunscreen is very personal, and people do not want to use a product just because of the SPF value, they want to use a product based on how it makes them feel,” he said.

At the end of the day, “the best sunscreen is the one a patient will use regularly and actually enjoy using,” Dr. Wang concluded.

Dr. Wang had no relevant financial conflicts to disclose.

MedscapeLive and this news organization are owned by the same parent company.

Pages

Recommended Reading

New lupus classification criteria perform well in children, young adults
MDedge Dermatology
Don’t discount ultrapotent topical corticosteroids for vulvar lichen sclerosus
MDedge Dermatology
A 31-year-old with a 3-week history of a waxing and waning, mildly pruritic eruption on his neck, chest, and back
MDedge Dermatology
New technologies show promise for treating pigmented lesions
MDedge Dermatology
Low IgA levels associated with increased infection risk in SLE patients
MDedge Dermatology
Systemic sclerosis patients share their perspectives and needs in treatment trials
MDedge Dermatology
A 4-year-old presented to our pediatric dermatology clinic for evaluation of asymptomatic "brown spots."
MDedge Dermatology
GLIMMER of hope for itch in primary biliary cholangitis
MDedge Dermatology
GLIMMER of hope for itch in primary biliary cholangitis
MDedge Dermatology
Expert shares key facts about keloid therapy
MDedge Dermatology